1Stanleyw C,Mariill IM.Metabolic therapy in the treatment of ischaemic heart disease:the pharmacology of trimetazidine[J].Fundam Clini Pharmacol,2003,17(2):133-145.
2Belardinelli R,Purcaro A.Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy[J].Eur Heart J,2001,22(23):2146-2170.
3Madamancui N R,Vendrov A,Runge M S.Oxidative stress and vascular disease[J].Arterioscler Thromb Vase Bio J,2005,25(1):29-38.
同被引文献12
1Dahlof B,Devereux R B,Kjeldsen SE,et al.Cardiovascularmorbidity and mortality in the Losartan Intervention ForEndpoint reduction in hypertension study(LIFE):a randomizedtrial against atenolool[J].Lancet,2002,359(9311):995-1003.
